Topic
1 story, newest first.
The Department of Health and Human Services has submitted a policy plan for peptide medications to the Office of Management and Budget for review. The American Academy of Peptide Medicine is listed as the requestor for the policy, which could impact how the FDA regulates certain peptide drugs.